Cipla receives South African health authoritys approval for 4-in-1 paediatric ARV formulation - Business Standard

Used to treat infants and young children with HIV Cipla announced that the South African Health Products Regulatory Authority (SAHPRA) has approved a sweet-tasting, heat-stable, '4-in-1' fixed-dose … [+2185 chars]

full article...